COMMUNIQUÉS West-GlobeNewswire

Burcon Announces Completion of Rights Offering

14/02/2018 - 14:32

VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon " or the " Company ") is pleased to announce the completion of its rights offering (the [...]

MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients

14/02/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell

14/02/2018 - 14:30

TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “ Company ” or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that the Company has received approval from the [...]

Agritek Holdings, Inc. Announces Licensing Deal With Pre-ICO Manufacturing Facility in California for Company’s Roll Out of California Premiums Exclusive Pre-Roll Brand

14/02/2018 - 14:30

LOS ANGELES, CA, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis [...]

Imaging3’s Newly Appointed CEO, John Hollister, Reflects on his First 45 Days at The Company

14/02/2018 - 14:30

BURBANK, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG); I joined Imaging3, a development stage company in Burbank, California, to target disruptive technologies in the medical imaging industry [...]

Avinger Announces Pricing of $18 Million Underwritten Public Offering

14/02/2018 - 14:30

REDWOOD CITY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the pricing of an underwritten [...]

Avadel Pharmaceuticals Announces Pricing of $125.0 Million 4.50% Exchangeable Senior Notes due 2023

14/02/2018 - 14:27

DUBLIN, Ireland, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ) (“Avadel” or “the Company”) today announced that its wholly-owned subsidiary, Avadel Finance Cayman Limited (the “Issuer”), [...]

Iovance Biotherapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference

14/02/2018 - 14:00

SAN CARLOS, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Poseida Therapeutics Presents Stem Cell Memory CAR-T Therapy for Prostate Cancer at 2018 Keystone Symposia on Emerging Cellular Therapies

14/02/2018 - 14:00

SAN DIEGO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, presented preclinical [...]

Tauriga Sciences, Inc. Fully Repays $27,500 Face Value 8.00% Convertible Debenture Issued to Adar Bays, LLC for One Time Cash Payment of $39,312.78

14/02/2018 - 14:00

New York, NY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK Current Tier: TAUG) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of [...]

Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference

14/02/2018 - 14:00

WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that Jesper Høiland, President and CEO of the Company, will present a corporate update at the 2018 RBC Capital [...]

Radius Health to Announce Fourth Quarter and Full Year 2017 Financial Results, Host Conference Call and Live Webcast on March 1, 2018

14/02/2018 - 14:00

WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that it will release its fourth quarter and full year 2017 financial results on Thursday, March 1, 2018. The Company [...]

Dynavax to Present at the RBC Capital Markets Global Healthcare Conference

14/02/2018 - 14:00

BERKELEY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s chief executive officer, will participate in a fireside chat at the 2018 [...]

Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis

14/02/2018 - 14:00

BUFFALO, N.Y., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer

14/02/2018 - 14:00

RA’ANANA, Israel and NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Sona Jasani, MD is Honored by the American Health Council for “Best in Medicine”

14/02/2018 - 14:00

NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Sona Jasani, MD as one of “America’s Best Doctors” for her unparalleled professional dedication and extraordinary contributions [...]

HempAmericana Fully Executes Contract To Acquire Local Farm for Seed Production

14/02/2018 - 14:00

NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the potential acquisition of a ten acres farm in Maine. The Company [...]

Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures

14/02/2018 - 14:00

DANVERS, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded U.S. Food and [...]

Inovalon Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

14/02/2018 - 13:55

BOWIE, Md., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]